Riabov V, Xu Q, Schmitt N, Streuer A, Ge G, Bolanos L, Wunderlich M, Jann J-C, Wein A, Altrock E, Demmerle M, Mukherjee S, Ali AM, Rapp F, Nowak V, Weimer N, Obländer J, Palme I, Göl M, Jawhar A, Darwich A, Wuchter P, Weiss C, Raza A, Foulks JM, Starczynowski DT, Yang F-C, Metzgeroth G, Steiner L, Jawhar M, Hofmann W-K, Nowak D. <i>ASXL1</i&gt; mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica 2024;109(5):1426-1438; https://doi.org/10.3324/haematol.2023.282921.